🔗 Share this article

An high-ranking medical official was removed of participation in an key research project on hormone suppressants after claims of preconceived views emerged.

Reported Involvement Resulted in Trial Pause

As reported by media accounts, Professor Jacob George, the chief medical director at the medicines regulator, raised concerns that caused the pausing of the national Pathways trial in early 2024.

This agency declared recently that the professor was recusing himself from involvement with the trial after skeptical online remarks posted in the past came to light.

Nature of Social Media Comments

Among a comment, George referred to writer the Harry Potter author being an asset of this era.” Elsewhere, the professor remarked that the rejection to accept basic biological fact was troubling” in relation to discussions over an Olympic athlete’s sex.

The regulator said how while the posts were posted prior to his role began, he had been taken off from oversight with the trial as an preventative measure.

Particulars Regarding the Paused Pathways Study

The clinical study, that was designed to evaluate the influence of hormone suppressants on young people exploring their gender, was scheduled to begin recruiting volunteers during January.

But, the trial was paused in February after the medicines regulator raised worries over the safety of young participants participating.

• Its most junior subjects were anticipated to start at 10 to 11 for assigned female at birth while 11 to 12 for assigned male at birth.
• Its trial leadership stated at the time that the strict selection process suggested participants would almost certainly be older.
• However, the agency have since recommended the minimum age limit ought to be 14 owing to an uncertain potential” for lasting biological harms.”

The study had planned to recruit around two hundred and twenty-six adolescents during the next three years.

Context Following the Independent Report

The study was commissioned after an urging by the Cass review on youth gender identity services, which concluded how the robustness of the research claiming to show the benefits of this type of medication for adolescents experiencing gender dysphoria were weak.”

Doctor Hilary Cass, who chaired that report, once stated her report “uncovered a notably limited evidence base” for the usefulness of such treatments.

She continued, since there are doctors, young people as well as families who believe deeply in the helpful results, research was the sole method forward to make sense of the situation.”

Expert Concern Regarding the Decision

Doctor Max Davie, an expert in adolescent medicine, argued there existed no strong evidence-based justification to suspend the study.

“The tweets from Professor George give a clear indication of his individual stance on this issue,” he said. “He is quite at liberty to have any opinions about gender identity he chooses, however what is improper would be to allow these opinions to influence the performance of his public duty.”

The doctor concluded: “For clarity, there is no definitive research justification to halt the Pathways trial. While the professor’s own views are not the sole plausible cause of the MHRA’s abrupt volte-face, it is the single factor for which supporting information.”

Agency Response and Next Steps

An MHRA representative commented: “In every clinical trials, our top priority remains the protection as well as wellbeing for the volunteers. In line with that promise, complex studies are kept continuously under review while the MHRA keeps an active discussion with research organizers.”

“We have expert medical, scientific and regulatory specialists who function in a multidisciplinary group to make research-informed decisions regarding medical research. These individuals will continue to engage alongside the organizers to navigate the future path productively.”

“After the discovery of social media posts made before his tenure began, Prof Jacob George was recused from any additional involvement with this study as an preventative step.”